Serum Levels of Anti-αGalactosyl Antibodies Predict Survival and Peritoneal Dialysis-Related Enteric Peritonitis Rates in Patients Undergoing Renal Replacement Therapy

American Journal of Kidney Diseases

Volumn 48, Issue 6, 2006, Pages 972-982

  Fontán, Miguel Pérez ^a   Máñez, Rafael ^a   Rodríguez Carmona, Ana ^a   Peteiro, Javier ^a   Martínez, Verónica ^a   García Falcón, Teresa ^a   Domenech, Nieves ^a  

^a HOSPITAL JUAN CANALEJO   (Spain)

Author keywords

anemia; Anti Galactosyl antibodies; hemodialysis (HD); inflammation; peritoneal dialysis (PD); peritonitis

Indexed keywords

ALPHA GALACTOSYL ANTIBODY; ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; MARKER; PIG HEMOLYTIC ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ANEMIA; ANTIBODY BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DEMOGRAPHY; DIALYSATE; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; KIDNEY ALLOGRAFT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; NUTRITIONAL STATUS; PERITONEAL DIALYSIS; PERITONEAL FLUID; PERITONITIS; RENAL REPLACEMENT THERAPY; SCHOOL CHILD; SURVIVAL RATE; TREATMENT OUTCOME; UNIVARIATE ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODIES; ANTIBODIES, HETEROPHILE; ASCITIC FLUID; CHI-SQUARE DISTRIBUTION; CHILD; DISACCHARIDES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; KIDNEY FAILURE, CHRONIC; LOGISTIC MODELS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONITIS; RENAL REPLACEMENT THERAPY; SWINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33845432499     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2006.08.027     Document Type: Article

References (27)

1. Galili U., Shohet S.B., Kobrin E., et al. Man, apes and Old-World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells. J Biol Chem 263 (1988) 17755-17762
2. Janeway C.A., and Medzhitov R. Innate immune recognition. Annu Rev Immunol 20 (2002) 197-216
3. Galili U., Anaraki F., Thall A., et al. One percent of human circulating B lymphocytes are capable of producing the natural anti-Gal antibody. Blood 8 (1993) 2485-2493
4. Bracy J.L., Cretin N., Cooper D.K., and Iacomini J. Xenoreactive natural antibodies. Cell Mol Life Sci 56 (1999) 1001-1007
5. Hamadeh R.M., Galili U., Zhou P., and Griffiss J.M. Anti-α-galactosyl immunoglobulin A (IgA), IgG and IgM in human secretions. Clin Diagn Lab Immunol 2 (1995) 125-131
6. Cooper D.K.C. Xenoantigens and xenoantibodies. Xenotransplantation 5 (1998) 6-17
7. Marcos M.A.R., Huetz F., Pereira P., et al. Further evidence for coelomic-associated B lymphocytes. Eur J Immunol 19 (1989) 2031-2035
8. + B cells. J Immunol 144 (1990) 4520-4525
9. Lalor P.A., and Morahan G. The peritoneal Ly-1 (CD5) B cell repertoire is unique among murine B cell repertoires. Eur J Immunol 20 (1990) 485-492
10. Marcos M.A.R., Gaspar M.L., Malenchere E., and Coutinho A. Isolation of peritoneal precursors of B-1 cells in the adult mouse. Eur J Immunol 24 (1994) 1033-1040
11. + B cells in the peritoneal cavity. Scand J Immunol 46 (1997) 541-545
12. Kawahara T., Ohdan H., Zhao G., et al. Peritoneal cavity B cells are precursors of splenic IgM natural antibody-producing cells. J Immunol 171 (2003) 5406-5414
13. Galili U., Mandrell R.E., Hamadeh R.M., et al. Interaction between human natural anti-α-galactosyl immunoglobulin G and bacteria of the human flora. Infect Immun 56 (1988) 1730-1737
14. Hamadeh R.M., Jarvis G.A., Galili U., et al. Human natural anti-Gal IgG regulates alternative complement pathway activation on bacterial surfaces. J Clin Invest 89 (1992) 1223-1235
15. Galili U., Flechner I., Knyszynski A., et al. The natural anti-α-galactosyl IgG on human normal senescent red blood cells. Br J Hematol 62 (1986) 1-4
16. Gabrielli A., Leoni P., Davieli G., et al. Antibodies against galactosyl α(1-3)galactose in connective tissue diseases. Arthritis Rheum 34 (1991) 375-376
17. Galili U., Wang L., LaTemple D.C., and Radic M.Z. The natural anti-Gal antibody. Subcell Biochem 32 (1999) 79-106
18. Pérez Fontán M., Mañez R., Blanco F., and Rodríguez-Carmona A. Natural anti-α-galactosyl antibodies in patients undergoing peritoneal dialysis and haemodialysis. Adv Perit Dial 16 (2000) 216-218
19. Charlson M.E., Pompei P., Ales K.L., and McKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 40 (1987) 373-383
20. Mañez R., Blanco F.J., Díaz I., et al. Removal of bowel anaerobic gram-negative bacteria is more effective than immunosuppression with cyclophosphamide and steroids to decrease natural α-galactosyl IgG antibodies. Xenotransplantation 8 (2001) 15-23
21. Buonomano R., Tinguely C., Rieben R., et al. Quantitation and characterization of anti-Gal-α-1,3-Gal antibodies in sera of 200 healthy persons. Xenotransplantation 5 (1999) 173-180
22. Díaz I., Veira P., Valdés F., et al. Quantitation and comparison of anti-Gal-α-1,3-Gal antibodies in sera of healthy individuals and patients waiting for kidney transplantation. Transplant Proc 35 (2003) 2043-2044
23. Wang L., Anaraki F., Henion T.R., and Galili U. Variations in activity of the human natural anti-Gal antibody in young and elderly populations. J Gerontol A Biol Sci Med Sci 50 (1995) 227-233
24. Donze H.H., Lue C., Julian B.A., et al. Human peritoneal B-1 cells and the influence of continuous ambulatory peritoneal dialysis on peritoneal and peripheral blood mononuclear cell (PBMC) composition and immunoglobulin levels. Clin Exp Immunol 109 (1997) 356-361
25. Fink M.P. Intestinal epithelial hyperpermeability: Update on the pathogenesis of gut mucosal barrier dysfunction in critical illness. Curr Opin Crit Care 9 (2003) 143-151
26. Ochsenbein A.F., Fehr T., Lutz C., et al. Control of early viral and bacterial distribution and disease by natural antibodies. Science 286 (1999) 2156-2159
27. Binder C.J., Shaw P.X., Chang M.K., et al. The role of natural antibodies in atherogenesis. J Lipid Res 46 (2005) 1353-1363